BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 35925904)

  • 1. Predictors of chronic COVID-19 symptoms in a community-based cohort of adults.
    Silverberg JI; Zyskind I; Naiditch H; Zimmerman J; Glatt AE; Pinter A; Theel ES; Joyner MJ; Hill DA; Lieberman MR; Bigajer E; Stok D; Frank E; Rosenberg AZ
    PLoS One; 2022; 17(8):e0271310. PubMed ID: 35925904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Varying Clinical Manifestations and Positive Anti-SARS-CoV-2 IgG Antibodies: A Cross-Sectional Observational Study.
    Silverberg JI; Zyskind I; Naiditch H; Zimmerman J; Glatt AE; Pinter A; Theel ES; Joyner MJ; Hill DA; Lieberman MR; Bigajer E; Stok D; Frank E; Rosenberg AZ
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3331-3338.e2. PubMed ID: 34273581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    Makaronidis J; Mok J; Balogun N; Magee CG; Omar RZ; Carnemolla A; Batterham RL
    PLoS Med; 2020 Oct; 17(10):e1003358. PubMed ID: 33001967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
    Thaweethai T; Jolley SE; Karlson EW; Levitan EB; Levy B; McComsey GA; McCorkell L; Nadkarni GN; Parthasarathy S; Singh U; Walker TA; Selvaggi CA; Shinnick DJ; Schulte CCM; Atchley-Challenner R; Alba GA; Alicic R; Altman N; Anglin K; Argueta U; Ashktorab H; Baslet G; Bassett IV; Bateman L; Bedi B; Bhattacharyya S; Bind MA; Blomkalns AL; Bonilla H; Brim H; Bush PA; Castro M; Chan J; Charney AW; Chen P; Chibnik LB; Chu HY; Clifton RG; Costantine MM; Cribbs SK; Davila Nieves SI; Deeks SG; Duven A; Emery IF; Erdmann N; Erlandson KM; Ernst KC; Farah-Abraham R; Farner CE; Feuerriegel EM; Fleurimont J; Fonseca V; Franko N; Gainer V; Gander JC; Gardner EM; Geng LN; Gibson KS; Go M; Goldman JD; Grebe H; Greenway FL; Habli M; Hafner J; Han JE; Hanson KA; Heath J; Hernandez C; Hess R; Hodder SL; Hoffman MK; Hoover SE; Huang B; Hughes BL; Jagannathan P; John J; Jordan MR; Katz SD; Kaufman ES; Kelly JD; Kelly SW; Kemp MM; Kirwan JP; Klein JD; Knox KS; Krishnan JA; Kumar A; Laiyemo AO; Lambert AA; Lanca M; Lee-Iannotti JK; Logarbo BP; Longo MT; Luciano CA; Lutrick K; Maley JH; Mallett G; Marathe JG; Marconi V; Marshall GD; Martin CF; Matusov Y; Mehari A; Mendez-Figueroa H; Mermelstein R; Metz TD; Morse R; Mosier J; Mouchati C; Mullington J; Murphy SN; Neuman RB; Nikolich JZ; Ofotokun I; Ojemakinde E; Palatnik A; Palomares K; Parimon T; Parry S; Patterson JE; Patterson TF; Patzer RE; Peluso MJ; Pemu P; Pettker CM; Plunkett BA; Pogreba-Brown K; Poppas A; Quigley JG; Reddy U; Reece R; Reeder H; Reeves WB; Reiman EM; Rischard F; Rosand J; Rouse DJ; Ruff A; Saade G; Sandoval GJ; Santana JL; Schlater SM; Sciurba FC; Shepherd F; Sherif ZA; Simhan H; Singer NG; Skupski DW; Sowles A; Sparks JA; Sukhera FI; Taylor BS; Teunis L; Thomas RJ; Thorp JM; Thuluvath P; Ticotsky A; Tita AT; Tuttle KR; Urdaneta AE; Valdivieso D; VanWagoner TM; Vasey A; Verduzco-Gutierrez M; Wallace ZS; Ward HD; Warren DE; Weiner SJ; Welch S; Whiteheart SW; Wiley Z; Wisnivesky JP; Yee LM; Zisis S; Horwitz LI; Foulkes AS;
    JAMA; 2023 Jun; 329(22):1934-1946. PubMed ID: 37278994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-acute sequelae of COVID-19 and longitudinal antibody levels in a community-based cohort.
    Kopplin N; Garcia A; Reczek A; Wilkinson K; Yekkaluri S; Murphy CC; Tiro J; Muthukumar AR; Masica A; Singal AG
    PLoS One; 2023; 18(9):e0291259. PubMed ID: 37682916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae.
    LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP
    BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up.
    Heidemann C; Sarganas G; Du Y; Gaertner B; Poethko-Müller C; Cohrdes C; Schmidt S; Schlaud M; Scheidt-Nave C
    BMC Public Health; 2023 Aug; 23(1):1587. PubMed ID: 37605232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    ; Wulf Hanson S; Abbafati C; Aerts JG; Al-Aly Z; Ashbaugh C; Ballouz T; Blyuss O; Bobkova P; Bonsel G; Borzakova S; Buonsenso D; Butnaru D; Carter A; Chu H; De Rose C; Diab MM; Ekbom E; El Tantawi M; Fomin V; Frithiof R; Gamirova A; Glybochko PV; Haagsma JA; Haghjooy Javanmard S; Hamilton EB; Harris G; Heijenbrok-Kal MH; Helbok R; Hellemons ME; Hillus D; Huijts SM; Hultström M; Jassat W; Kurth F; Larsson IM; Lipcsey M; Liu C; Loflin CD; Malinovschi A; Mao W; Mazankova L; McCulloch D; Menges D; Mohammadifard N; Munblit D; Nekliudov NA; Ogbuoji O; Osmanov IM; Peñalvo JL; Petersen MS; Puhan MA; Rahman M; Rass V; Reinig N; Ribbers GM; Ricchiuto A; Rubertsson S; Samitova E; Sarrafzadegan N; Shikhaleva A; Simpson KE; Sinatti D; Soriano JB; Spiridonova E; Steinbeis F; Svistunov AA; Valentini P; van de Water BJ; van den Berg-Emons R; Wallin E; Witzenrath M; Wu Y; Xu H; Zoller T; Adolph C; Albright J; Amlag JO; Aravkin AY; Bang-Jensen BL; Bisignano C; Castellano R; Castro E; Chakrabarti S; Collins JK; Dai X; Daoud F; Dapper C; Deen A; Duncan BB; Erickson M; Ewald SB; Ferrari AJ; Flaxman AD; Fullman N; Gamkrelidze A; Giles JR; Guo G; Hay SI; He J; Helak M; Hulland EN; Kereselidze M; Krohn KJ; Lazzar-Atwood A; Lindstrom A; Lozano R; Malta DC; Månsson J; Mantilla Herrera AM; Mokdad AH; Monasta L; Nomura S; Pasovic M; Pigott DM; Reiner RC; Reinke G; Ribeiro ALP; Santomauro DF; Sholokhov A; Spurlock EE; Walcott R; Walker A; Wiysonge CS; Zheng P; Bettger JP; Murray CJL; Vos T
    JAMA; 2022 Oct; 328(16):1604-1615. PubMed ID: 36215063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subphenotypes of self-reported symptoms and outcomes in long COVID: a prospective cohort study with latent class analysis.
    Kitsios GD; Blacka S; Jacobs JJ; Mirza T; Naqvi A; Gentry H; Murray C; Wang X; Golubykh K; Qurashi H; Dodia A; Risbano M; Benigno M; Emir B; Weinstein E; Bramson C; Jiang L; Dai F; Szigethy E; Mellors JW; Methe B; Sciurba FC; Nouraie SM; Morris A
    BMJ Open; 2024 Mar; 14(3):e077869. PubMed ID: 38485476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study.
    Horton DB; Barrett ES; Roy J; Gennaro ML; Andrews T; Greenberg P; Bruiners N; Datta P; Ukey R; Velusamy SK; Fine D; Honnen WJ; Yin YS; Pinter A; Brooks A; Tischfield J; Hussain S; Jagpal S; Swaminathan S; Parmar V; Reilly N; Gaur S; Panettieri RA; Carson JL; Blaser MJ
    J Infect Dis; 2021 Oct; 224(8):1345-1356. PubMed ID: 34387310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saliva antibody-fingerprint of reactivated latent viruses after mild/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis/chronic fatigue syndrome.
    Apostolou E; Rizwan M; Moustardas P; Sjögren P; Bertilson BC; Bragée B; Polo O; Rosén A
    Front Immunol; 2022; 13():949787. PubMed ID: 36341457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response three months after SARS-CoV-2 infection.
    Oktay Gültekin E; Gültekin O; Coskun A; Aksak T
    J Med Virol; 2022 Oct; 94(10):4712-4718. PubMed ID: 35655391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
    Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
    Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study.
    Borch L; Holm M; Knudsen M; Ellermann-Eriksen S; Hagstroem S
    Eur J Pediatr; 2022 Apr; 181(4):1597-1607. PubMed ID: 35000003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID-19 Fatigue and SARS-CoV-2 Specific Humoral and T-Cell Responses in Male and Female Outpatients.
    Meisinger C; Goßlau Y; Warm TD; Leone V; Hyhlik-Dürr A; Linseisen J; Kirchberger I
    Front Immunol; 2022; 13():902140. PubMed ID: 35693828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
    Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
    PLoS One; 2020; 15(10):e0241104. PubMed ID: 33085715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world effectiveness of COVID-19 vaccines and anti-SARS-CoV-2 monoclonal antibodies against postacute sequelae of SARS-CoV-2: analysis of a COVID-19 observational registry for a diverse US metropolitan population.
    Tannous J; Pan AP; Potter T; Bako AT; Dlouhy K; Drews A; Sostman HD; Vahidy FS
    BMJ Open; 2023 Apr; 13(4):e067611. PubMed ID: 37019490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
    Lumley SF; Wei J; O'Donnell D; Stoesser NE; Matthews PC; Howarth A; Hatch SB; Marsden BD; Cox S; James T; Peck LJ; Ritter TG; de Toledo Z; Cornall RJ; Jones EY; Stuart DI; Screaton G; Ebner D; Hoosdally S; Crook DW; Conlon CP; Pouwels KB; Walker AS; Peto TEA; Walker TM; Jeffery K; Eyre DW;
    Clin Infect Dis; 2021 Aug; 73(3):e699-e709. PubMed ID: 33400782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2.
    Wohl DA; Barzin AH; Napravnik S; Davy-Mendez T; Smedberg JR; Thompson CM; Ruegsegger L; Gilleskie M; Weber DJ; Whinna HC; Miller MB
    PLoS One; 2021; 16(12):e0260879. PubMed ID: 34890441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.